Search results
Results from the WOW.Com Content Network
This is a list of investigational autism and pervasive developmental disorder drugs, or drugs that are currently under development for clinical use in the treatment of autistic spectrum disorders and/or other pervasive developmental disorders but are not yet approved.
This is a list of psychiatric medications used by psychiatrists and other physicians to treat mental illness or distress. The list is ordered alphabetically according to the condition or conditions, then by the generic name of each medication. The list is not exhaustive and not all drugs are used regularly in all countries.
More specifically, prevalence estimates of catatonia among people with neurodevelopmental disorders (of which autism is one) have ranged from 6-20.2%, with the mean estimate falling at 9%; [1] similarly, in a recent meta-analysis of 12 studies of autistic catatonia, Vaquerizo-Serrano et al. suggest that catatonia is found in 10.4% of autistic ...
In January 2018, Roche announced that the US Food and Drug Administration (FDA) had granted breakthrough therapy designation for balovaptan in people with autism spectrum disorder (ASD). [3] The FDA granted this based on the results of the adult phase II clinical trial called VANILLA (Vasopressin ANtagonist to Improve sociaL communication in ...
The reason given is: information needs to be updated to reflect substantiation of the efficacy of early intervention in the treatment of autism and more recent attitudes toward Applied Behavioral Analysis, TEACCH, and the subject of treating people with autism. Please help update this article to reflect recent events or newly available information.
ReVia – an opioid antagonist primarily used in the management of alcohol dependence, opioid dependence or other impulse control/addictive behaviors such as habitual self-mutilation; Rexulti (brexpiprazole) – atypical antipsychotic used to treat mood and psychotic disorders
Autism spectrum disorder [a] (ASD), or simply autism, is a neurodevelopmental disorder "characterized by persistent deficits in social communication and social interaction across multiple contexts" and "restricted, repetitive patterns of behavior, interests, or activities". [11]
Also, the social difficulties often experienced by individuals with ADHD due to inattention (e.g., being unfocused during the interaction and therefore missing cues or being unaware of one's behavior) [235] or impulsivity (blurting things out, asking intrusive questions, interrupting) may be contrasted with the social detachment and deficits in ...